Stay updated on Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial
Sign up to get notified when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.
Latest updates to the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page
- CheckyesterdayChange DetectedThe study has increased its participant count from 36 to 38 and added new recruiting locations in New York and Dallas.SummaryDifference1%
- Check9 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check16 days agoChange DetectedThe website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in study record information.SummaryDifference0.7%
- Check23 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.6%
- Check31 days agoChange DetectedThe website has added new dates for upcoming events in September 2024 while removing previous recruiting information from mid-August.SummaryDifference0.5%
- Check38 days agoChange DetectedThe website has been updated from version v2.10.2 to v2.10.3.SummaryDifference0.1%
Stay in the know with updates to Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.